The collaboration aims to discover and develop molecular glue degrader clinical candidates for priority targets to Biogen. Collaboration leverages Neomorph's leading molecular glue discovery platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback